Skip to content

Darunavir/ritonavir superior virologically and immunologically to comparator drugs over one year

Two-class ART just as good as three-class in the long-term, and has fewer side-effects

Brain problems and peripheral neuropathy under-diagnosed in Asia and the Pacific

Randomised trial of food supplementation in food insecure patients ART inconclusive

Very low CD4, rural care, linked to higher risk of death on ARVs in African studies

Selenium improves ART response in Nigerian randomised study

Duration of HIV infection and duration of HIV therapy use risk factors for bone disease

Genetics associated with risk of severe allergic reaction to nevirapine

Lowered AZT dose for low weight patients 'effective and reduces toxicity'